Chemoinformaics analysis of GAMMA-TOCOTRIENOL
| Molecular Weight | 410.642 | nRot | 9 |
| Heavy Atom Molecular Weight | 368.306 | nRig | 14 |
| Exact Molecular Weight | 410.318 | nRing | 2 |
| Solubility: LogS | -6.056 | nHRing | 1 |
| Solubility: LogP | 9.419 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 76.3693 |
| nHD | 1 | BPOL | 43.8707 |
| QED | 0.415 |
| Synth | 3.618 |
| Natural Product Likeliness | 2.13 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.206 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.747 |
| MDCK | 0.0000139 |
| BBB | 0.151 |
| PPB | 0.960054 |
| VDSS | 9.646 |
| FU | 0.0454807 |
| CYP1A2-inh | 0.329 |
| CYP1A2-sub | 0.181 |
| CYP2c19-inh | 0.383 |
| CYP2c19-sub | 0.765 |
| CYP2c9-inh | 0.388 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.645 |
| CYP2d6-sub | 0.462 |
| CYP3a4-inh | 0.547 |
| CYP3a4-sub | 0.155 |
| CL | 14.602 |
| T12 | 0.024 |
| hERG | 0.091 |
| Ames | 0.006 |
| ROA | 0.01 |
| SkinSen | 0.879 |
| Carcinogencity | 0.227 |
| EI | 0.105 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.712 |
| Antiviral | No |
| Prediction | 0.610146 |